Hexoprenaline Sulfate
| Code | Size | Price |
|---|
| TAR-T27540-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
| TAR-T27540-50mg | 50mg | £1,661.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
| TAR-T27540-100mg | 100mg | £2,079.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
Hexoprenaline Sulfate is a selective beta2-adrenoreceptor agonist. Hexoprenaline Sulfate is active in man as a bronchodilator by the oral or intravenous routes and by inhalation. Hexoprenaline Sulfate is indicated for use in the treatment of bronchospasm associated with obstructive airways diseases, including bronchitis, asthma and emphysema.
CAS:
32266-10-7
Formula:
C22H34N2O10S
Molecular Weight:
518.58
Purity:
0.98
SMILES:
OS(O)(=O)=O.OC(CNCCCCCCNCC(O)c1ccc(O)c(O)c1)c1ccc(O)c(O)c1
References
1. Trittenwein G, Rosegger H, Beitzke A, Lichtenegger W, Rosanelli K, Zeichen HL. [Heart function in infants and small children, whose mothers required tocolysis with hexoprenaline sulfate (Gynipral)]. Wien Klin Wochenschr. 1986 Sep 26;98(18):613-7. German. PubMed PMID: 3788179.
2. Rivier G, Nicole A, Stucki D, Regamey C. [Lesional pulmonary edema associated with tocolysis by hexoprenaline sulfate]. Schweiz Med Wochenschr. 1992 Feb 15;122(7):237-41. French. PubMed PMID: 1539126.
3. Niveiro E, Oehling A. [Hexoprenaline sulfate in the treatment of bronchospastic processes]. Allergol Immunopathol (Madr). 1974 Nov-Dec;2(6):387-98. Spanish. PubMed PMID: 4464780.
4. Mayer M, Minichmayr A, Klement F, Hroncek K, Wertaschnigg D, Arzt W, Wiesinger-Eidenberger G, Lechner E. Tocolysis with the ?-2-sympathomimetic hexoprenaline increases occurrence of infantile haemangioma in preterm infants. Arch Dis Child Fetal Neonatal Ed. 2013 Mar;98(2):F108-11. doi: 10.1136/archdischild-2011-301030. Epub 2012 May 18. PubMed PMID: 22611112.